Survival rates for patients with blood cancers like leukemia and lymphoma – diseases that not that long ago were considered all but incurable – have increased dramatically.
According to the Leukemia & Lymphoma Society, the five-year survival rates for patients diagnosed with leukemia from 1960-63 was just 14 percent. Fifty years later, it reached 61 percent.
For Hodgkin lymphoma, the five-year survival rate has gone from 40 percent to 88 percent. Five-year survival rates for non-Hodgkin lymphoma has also improved from 31 percent to 73 percent since the 1960s.
“I can’t help but be proud and gratified that I work for an organization that has helped improve the survival rate of blood cancers,” said Dr. Rachel Beddard, Chief Medical Officer at BioBridge Global.